Safety and efficacy of omadacycline by BMI categories and diabetes history in two Phase III randomized studies of patients with acute bacterial skin and skin structure infections.

J Antimicrob Chemother · 2021 · PMC8050767 · PMID 33458763

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

There was a numerical trend towards increases in rates of nausea, vomiting and headache with increasing BMI classification, regardless of patient treatment group.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.